Other languages BioHarvest Sciences Inc. Deutsche Boerse AG

Equities

8MV0

CA09076J2074

Delayed Deutsche Boerse AG Other stock markets 11:35:20 25/06/2024 am IST			5-day change	1st Jan Change
5.63 ^EUR	+4.07%		+0.36%	+15.72%

21/06	BioHarvest Sciences Announces US$5 Million Private-Placement Financing, Conversion of Debt Notes	MT
21/06	BioHarvest Sciences Inc. announced that it expects to receive CAD 6.847977 million in funding	CI

Other languages

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

BioHarvest Sciences Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	30/05
BioHarvest Sciences Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	30/04
BioHarvest Sciences Inc. Provides Revenue Guidance for the First Quarter and Second Quarter of 2024	30/04
BioHarvest Sciences Inc. Announces New Campus for Botanical Synthesis CDMO and Expansion of Manufacturing Capacity	16/04
BioHarvest Sciences Inc. Announces Launch of New Contract Development and Manufacturing Organization Business Unit	26/02
BioHarvest Sciences Inc. Signs First Contracts with Two Industrial Customers to Develop Complex Molecules Via Its Newly Launched Botanical Synthesis CDMO Business Unit	26/02
Bioharvest Sciences Inc. Announces Major Product Launch of Vinia-Based Functional Coffee Products	13/12
BioHarvest Sciences Inc. Provides Revenue Guidance for the Fourth Quarter 2023	29/11
Bioharvest Sciences Inc. Revises Revenue Guidance for the Year 2023	29/11
BioHarvest Sciences Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	28/11
BioHarvest Sciences Inc. Receives Canadian Product License from Health Canada's Natural and Non-Prescription Health Products Directorate	10/23/10
BioHarvest Sciences Inc. Provides Revenue Guidance for the Third Quarter of 2023	30/23/30
BioHarvest Sciences Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	29/23/29
BioHarvest Sciences Inc. Announces Appointment of John Paul Sangiovanni as Medical and Scientific Advisory Board	06/23/06
Bioharvest Sciences Inc. Reiterated Sales Guidance for the year 2023	31/23/31
BioHarvest Sciences Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	31/23/31
BioHarvest Sciences Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	28/23/28
BioHarvest Sciences Inc. Auditor Raises 'Going Concern' Doubt	27/23/27
Bioharvest Sciences Inc. Hires Dr. Ilana Belzer as Chief Operating Officer	19/23/19
BioHarvest Sciences Inc. Announces Clinical Study in Patients with Multiple Sclerosis-Related Optic Neuritis	14/23/14

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages BioHarvest Sciences Inc. Deutsche Boerse AG

Equities

8MV0

CA09076J2074

Other languages

Filters